期刊语言：英语

出版地区：美国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：https://www.springer.com/journal/417

3、投稿网址：http://www.editorialmanager.com/grae

4、官网邮箱：graefes_archive@di-ep.com（编辑部）

更多相关咨询邮箱如下。

5、官网电话：+44-141-644-3900（编辑部）

6、期刊刊期：月刊，一年出版12期。

2021年6月1日星期二

期刊相关咨询邮箱【官网信息】

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Jamaica Bihasa (Jamaica.Bihasa@springernature.com).

Publication-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Lori Des Concepcion (LoriDes.Concepcion@springernature.com).

Other editorial enquiries

Any other queries about the journal or presubmission enquiries should be sent to Patrizia Bianchi (patrizia.bianchi@springer.com).

投稿须知【官网信息】

Submission guidelines

Instructions for Authors

General

Ocular Trauma Terminology

Terminology used in descriptions of ocular trauma should conform to the recommendations of the United States Eye Injury Registry and the International Society of Ocular Trauma Birmingham Eye Trauma Terminology (BETT): Kuhn F, Morris R, Witherspoon D, et al. (1996) A standard classification of ocular trauma. Graefe’s Arch 234:399–403.

Nomenclature for Ophthalmic Malignancies. Authors should use the American Joint Commission on Cancer TNM classification scheme when describing patients with ophthalmic malignancies (American Joint Commission on Cancer. AJCC Cancer Staging Manual. New York, NY: Springer; 2017).

Conflicts of opinion-you may mention up to 3 institutes/individuals with whom you have a conflict of opinion.

Editorial Procedure

All submissions must be uploaded with the authorship form. The form must be signed by all named authors.

Please be sure to include your e-mail address and your fax number. Senior co-authors should note that they have the responsibility to read and edit manuscripts bearing their name.

Authorship form

editorialmanager.com/graefes

Editorial Office

Di-Ep Biomedical Editorial Services Ltd

“Millworks”

28 Field Road

Glasgow G76-8SE

Scotland, UK

Tel: +44-141-644-3900

Fax:+44-141-244-0125

Di-Ep Biomed Edit Services

Types of Papers

The journal is introducing a new section for all papers: Key messages.

Two-Four key messages are required, 1 key message should note what is known and 2-3 key messages should highlight the new information in the paper.

The key messages should be placed on the Title Page (prior to the Abstract).

Accepted Article Types:

- Full Papers

Full Papers have a strict limit of 9 named authors.

If a Study group is involved please list the 8 named authors responsible for the research, add XXX study group. Add an appendix to the paper with the additional authors names and affiliations and/or countries.

If there are over 9 named authors involved in the research but this is not a study group please contact the editorial office by email : graefes_archive@di-ep.com for advice PRIOR to submission.

Full papers are divided between the following sections:

• Basic Science

• Cataract

• Cornea

• Genetics

• Glaucoma

• Inflammatory disorders

• Low Vision

• Medical Ophthalmology

• Neurophthalmology

• Oculoplastics and Orbit

• Oncology

• Pathology

• Pediatrics

• Refractive Surgery

• Retinal Disorders

• Trauma

• Miscellaneous

- Review Articles

Suggestions for review articles are welcome and should be submitted directly to the Editorial Office at: Graefes_archive@di-ep.com

- Review Articles have a strict limit of 9 named authors.

If a Study group is involved please list the 8 named authors responsible for the research, add XXX study group. Add an appendix to the paper with the additional authors names and affiliations and/or countries.

If there are over 9 named authors involved in the research but this is not a study group please contact the editorial office by email : graefes_archive@di-ep.com for advice PRIOR to submission.

- Letter to the Editor

Requires a title page, limit of 4 named authors, begin with the words “Dear Editor”, contain between 500-600 words. Max of 1 figure and 1 table or alternatively 2 figures or 2 tables. Limit of 10 references. Keywords should be placed at end of letter. A conflict of interest statement is required for all letters. If required a patient disclosure statement should be placed at the end of the letter.

Please note: for this category no abstract is required.

- Book Review

- Editorials

Currently Graefe’s Archive for Clinical and Experimental Ophthalmology does not consider case reports.

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Abstract

Please provide a structured abstract of 150 to 250 words which should be divided into the following sections:

Purpose (stating the main purposes and research question)

Methods

Results

Conclusion

For life science journals only (when applicable)

Trial registration number and date of registration

Trial registration number, date of registration followed by “retrospectively registered”

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

Declarations

All manuscripts must contain the following sections under the heading 'Declarations'.

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.

To be used for all articles, including articles with biological applications

Funding (information that explains whether and by whom the research was supported)

Conflicts of interest/Competing interests (include appropriate disclosures)

Availability of data and material (data transparency)

Code availability (software application or custom code)

Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)

Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals

Ethics approval (include appropriate approvals or waivers)

Consent to participate (include appropriate statements)

Consent for publication (include appropriate statements)

Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.

……

更多详情：

https://www.springer.com/journal/417/submission-guidelines